Garvan Institute of Medical Research

The Garvan Institute of Medical Research was founded in 1963 by the Sisters of Charity. Initially a research department of St Vincent's Hospital in Sydney, it is now one of Australia's largest medical research institutions with approximately 500 scientists, students and support staff. Funds for its establishment were provided by a hospital appeal. Helen Mills, the largest donor, asked for the centre to be named after her father, the late James Patrick Garvan (1843-1896), a distinguished New South Wales parliamentarian and business leader. Garvan's research programs are based around the major diseases in today's society: cancer, diabetes, osteoporosis, Alzheimer's, Parkinson's; as well as eating disorders, and autoimmune and inflammatory conditions such as rheumatoid arthritis and asthma. It specialises in genetic and molecular technologies, and emphasises collaborative research. The current director is John Mattick.

Website
http://www.garvan.org.au
Wikipedia
http://en.wikipedia.org/wiki/Garvan_Institute_of_Medical_Research

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Alzheimer's disease & dementia

Metformin treatment linked to slowed cognitive decline

Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimize their blood glucose levels.

Immunology

Extinct human species gave modern humans an immunity boost

Findings from the Garvan Institute of Medical Research show modern humans acquired a gene variant from Denisovans that heightened their immune reactions, indicating adaptation of the immune system to a changing environment.

Immunology

A trigger that likely unleashes autoimmune disease

Australian researchers believe they have discovered a group of cells that trigger autoimmune disease, as well as the molecular 'trigger guard' that normally holds them in check.

page 1 from 12